Skip to main content
. 2016 Oct 13;2016:3267307. doi: 10.1155/2016/3267307

Figure 3.

Figure 3

Within-group effect sizes calculated from the Superion IDE trial in contrast with comparable effect size extrapolated from the SPORT trial [5] for ODI outcomes at 2, 3, and 4 years of follow-up and from Strömqvist et al. [6] for ZCQ symptom severity (ss) and physical function (pf) at 2 years of follow-up.